A new study by F.D.A. scientists found that some products contained more than six times the amount on the label.

Zantac 360 Famotidine may also be used for purposes ... Use Pepcid AC (Famotidine Oral Injection) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Britney Spears and Kevin Federline's 2 Kids: All About Sean and Jayden All About Britney Spears' Younger Son Jayden James Federline Amy Slaton's 2 Kids: All About Gage and Glenn Lin-Manuel Miranda ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense ... submission of a false product labels … [and] submission of false and misleading supplemental applications” – From ...

So this is the same on any label that you look at on any food. Narrator Emory University nutritionist Julie Schwartz prepped the kids before the hunt with an in-depth explanation on how to read a ...

by Courtney Schley and James Austin These games can introduce kids to new genres, help them build skills, and offer provocative and age-appropriate challenges, engaging themes, and distinctive ...

(Bloomberg) -- GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Millions of children have no access to education, work long hours under hazardous conditions, or have their safety and futures threatened by armed conflict. They suffer targeted attacks on their ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.